Multiple Sclerosis Clinical Trials in Los Angeles

Showing 201-220 of 269 trials

Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis

NCT00185848

The purpose of this study is to determine whether \[18F\]FHBG is suitable for use as an imaging probe in cancer or rheumatoid arthritis patients enrolled in cell or gene therapy trials. In this phase 1 study we will assess the safety and biodistribution of \[18F\]FHBG in patients.

Brain CancerArthritis, RheumatoidCentral Nervous System Neoplasms+1 more

Sanjiv Sam Gambhir10 participantsStarted Apr 2005

Los Angeles, California, United States • Stanford, California, United States

COMPLETEDPHASE3< 1 mile

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer

NCT00056446

The purpose of this study is to compare treatment with oxaliplatin/5-FU/leucovorin plus vatalanib versus oxaliplatin/5-FU/leucovorin plus placebo in patients with colorectal cancer that has spread to other organs and whose disease has worsened after treatment with irinotecan.

Colorectal NeoplasmsColonic NeoplasmsRectal Neoplasms

Novartis Pharmaceuticals855 participantsStarted Jan 2003

Huntsville, Alabama, United States • Anchorage, Alaska, United States • Tucson, Arizona, United States +248 more locations

Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer

Multiple Sclerosis Trials in Other Cities

Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.

A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer

Safety, Tolerability, and Pharmacokinetics of Onartuzumab Combined With Vemurafenib and/or Cobimetinib in Cancer Patients

Locomotor Training in Persons With Multiple Sclerosis

Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer

A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

EPO906 Therapy in Patients With Prostate Cancer

Safety and Tolerability of Glatiramer Acetate

A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Efficacy and Safety of GTR in Comparison to Copaxone®

Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis

Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

BIBW 2992 (Afatinib) in Head & Neck Cancer

Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis

Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study

Real-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab)

JC-Virus (JCV) Antibody Program

Other Conditions in Los Angeles